Flexion's knee pain drug gets FDA nod
October 06, 2017 at 15:07 PM EDT
Oct 6 (Reuters) - Flexion Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its drug, Zilretta, to treat moderate-to-severe osteoarthritis-related knee pain.
